{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:16:13Z","timestamp":1794935773221,"version":"4.9.1"},"reference-count":51,"publisher":"Pharmaceutical Society of Japan","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1248\/bpb.b21-00457","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T22:14:48Z","timestamp":1633040088000},"page":"1536-1547","source":"Crossref","is-referenced-by-count":59,"title":["Norisoboldine Attenuates Sepsis-Induced Acute Lung Injury by Modulating Macrophage Polarization &lt;i&gt;via&lt;\/i&gt; PKM2\/HIF-1\u03b1\/PGC-1\u03b1 Pathway"],"prefix":"10.1248","volume":"44","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebo","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkui","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, the First People's Hospital of Fuyang District"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Hamers L, Kox M, Pickkers P. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options. <i>Minerva Anestesiol.<\/i>, <b>81<\/b>, 426\u2013439 (2015)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. <i>Front. Immunol.<\/i>, <b>11<\/b>, 1722 (2020).","DOI":"10.3389\/fimmu.2020.01722"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Laskin DL, Malaviya R, Laskin JD. Role of macrophages in acute lung injury and chronic fibrosis induced by pulmonary toxicants. <i>Toxicol. Sci.<\/i>, <b>168<\/b>, 287\u2013301 (2019).","DOI":"10.1093\/toxsci\/kfy309"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Camprub\u00ed-Rimblas M, Tantiny\u00e0 N, Guillamat-Prats R, Bringu\u00e9 J, Puig F, G\u00f3mez MN, Blanch L, Artigas A. Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats. <i>J. Thromb. Haemost.<\/i>, <b>18<\/b>, 571\u2013583 (2020).","DOI":"10.1111\/jth.14685"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Andersson U. The cholinergic anti-inflammatory pathway alleviates acute lung injury. <i>Mol. Med.<\/i>, <b>26<\/b>, 64 (2020).","DOI":"10.1186\/s10020-020-00184-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Huang XT, Liu W, Zhou Y, Sun M, Yang HH, Zhang CY, Tang SY. Galectin-1 ameliorates lipopolysaccharide-induced acute lung injury <i>via<\/i> AMPK\u2013Nrf2 pathway in mice. <i>Free Radic. Biol. Med.<\/i>, <b>146<\/b>, 222\u2013233 (2020).","DOI":"10.1016\/j.freeradbiomed.2019.11.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Liegeois M, Legrand C, Desmet CJ, Marichal T, Bureau F. The interstitial macrophage: a long-neglected piece in the puzzle of lung immunity. <i>Cell. Immunol.<\/i>, <b>330<\/b>, 91\u201396 (2018).","DOI":"10.1016\/j.cellimm.2018.02.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kulshrestha R, Dhanda H, Pandey A, Singh A, Kumar R. Immunopathogenesis and therapeutic potential of macrophage influx in diffuse parenchymal lung diseases. <i>Expert Rev. Respir. Med.<\/i>, <b>14<\/b>, 917\u2013928 (2020).","DOI":"10.1080\/17476348.2020.1776117"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Patoli D, Mignotte F, Deckert V, <i>et al.<\/i> Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. <i>J. Clin. Invest.<\/i>, <b>130<\/b>, 5858\u20135874 (2020).","DOI":"10.1172\/JCI130996"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Yan X, Tu H, Liu Y, Chen T, Cao J. Interleukin-17D aggravates sepsis by inhibiting macrophage phagocytosis. <i>Crit. Care Med.<\/i>, <b>48<\/b>, e58\u2013e65 (2020).","DOI":"10.1097\/CCM.0000000000004070"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. <i>J. Leukoc. Biol.<\/i>, <b>106<\/b>, 345\u2013358 (2019).","DOI":"10.1002\/JLB.3RU1018-378RR"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. <i>Eur. J. Pharmacol.<\/i>, <b>877<\/b>, 173090 (2020).","DOI":"10.1016\/j.ejphar.2020.173090"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Wang S, Cao M, Xu S, Shi J, Mao X, Yao X, Liu C. Luteolin alters macrophage polarization to inhibit inflammation. <i>Inflammation<\/i>, <b>43<\/b>, 95\u2013108 (2020).","DOI":"10.1007\/s10753-019-01099-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Jing Y, Wu F, Li D, Yang L, Li Q, Li R. Metformin improves obesity-associated inflammation by altering macrophages polarization. <i>Mol. Cell. Endocrinol.<\/i>, <b>461<\/b>, 256\u2013264 (2018).","DOI":"10.1016\/j.mce.2017.09.025"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Blum L, Geisslinger G, Parnham MJ, Gr\u00fcnweller A, Schiffmann S. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells. <i>J. Cell. Mol. Med.<\/i>, <b>24<\/b>, 6988\u20136999 (2020).","DOI":"10.1111\/jcmm.15360"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Xu M, Li X, Song L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia\/reperfusion injury <i>via<\/i> inhibiting JAK\/STAT pathway. <i>Pharm. Biol.<\/i>, <b>58<\/b>, 655\u2013663 (2020).","DOI":"10.1080\/13880209.2020.1779318"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Viola A, Munari F, S\u00e1nchez-Rodr\u00edguez R, Scolaro T, Castegna A. The metabolic signature of macrophage responses. <i>Front. Immunol.<\/i>, <b>10<\/b>, 1462 (2019).","DOI":"10.3389\/fimmu.2019.01462"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wang Z, Kong L, Tan S, Zhang Y, Song X, Wang T, Lin Q, Wu Z, Xiang P, Li C, Gao L, Liang X, Ma C. Zhx2 accelerates sepsis by promoting macrophage glycolysis <i>via<\/i> Pfkfb3. <i>J. Immunol.<\/i>, <b>204<\/b>, 2232\u20132241 (2020).","DOI":"10.4049\/jimmunol.1901246"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Xu D, Liang J, Lin J, Yu C. PKM2: a potential regulator of rheumatoid arthritis <i>via<\/i> glycolytic and non-glycolytic pathways. <i>Front. Immunol.<\/i>, <b>10<\/b>, 2919 (2019).","DOI":"10.3389\/fimmu.2019.02919"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Li T, Han J, Jia L, Hu X, Chen L, Wang Y. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation. <i>Protein Cell<\/i>, <b>10<\/b>, 583\u2013594 (2019).","DOI":"10.1007\/s13238-019-0618-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Xie M, Yu Y, Kang R, Zhu S, Yang L, Zeng L, Sun X, Yang M, Billiar TR, Wang H, Cao L, Jiang J, Tang D. PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation. <i>Nat. Commun.<\/i>, <b>7<\/b>, 13280 (2016).","DOI":"10.1038\/ncomms13280"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Liu H, Takagaki Y, Kumagai A, Kanasaki K, Koya D. The PKM2 activator TEPP-46 suppresses kidney fibrosis <i>via<\/i> inhibition of the EMT program and aberrant glycolysis associated with suppression of HIF-1\u03b1 accumulation. <i>J. Diabetes Investig.<\/i>, <b>12<\/b>, 697\u2013709 (2021).","DOI":"10.1111\/jdi.13478"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Shirai T, Nazarewicz RR, Wallis BB, Yanes RE, Watanabe R, Hilhorst M, Tian L, Harrison DG, Giacomini JC, Assimes TL, Goronzy JJ, Weyand CM. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. <i>J. Exp. Med.<\/i>, <b>213<\/b>, 337\u2013354 (2016).","DOI":"10.1084\/jem.20150900"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pan L, Hu L, Zhang L, Xu H, Chen Y, Bian Q, Zhu A, Wu H. Deoxyelephantopin decreases the release of inflammatory cytokines in macrophage associated with attenuation of aerobic glycolysis <i>via<\/i> modulation of PKM2. <i>Int. Immunopharmacol.<\/i>, <b>79<\/b>, 106048 (2020).","DOI":"10.1016\/j.intimp.2019.106048"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Huang M, Su J, Lou Z, Xie F, Pan W, Yang Z, Gu L, Xie F, Xu Z, Zhang L, Liu F, Lai H, Zhang L, Lin N. Application of a DSS colitis model in toxicologically assessing norisoboldine. <i>Toxicol. Mech. Methods<\/i>, <b>30<\/b>, 107\u2013114 (2020).","DOI":"10.1080\/15376516.2019.1669242"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Lv Q, Wang K, Qiao S, Yang L, Xin Y, Dai Y, Wei Z. Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis <i>via<\/i> targeting glycolysis and subsequent NAD(+)\/SIRT1\/SUV39H1\/H3K9me3 signaling pathway. <i>Cell Death Dis.<\/i>, <b>9<\/b>, 258 (2018).","DOI":"10.1038\/s41419-018-0297-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Duan C, Guo JM, Dai Y, Xia YF. The absorption enhancement of norisoboldine in the duodenum of adjuvant-induced arthritis rats involves the impairment of P-glycoprotein. <i>Biopharm. Drug Dispos.<\/i>, <b>38<\/b>, 75\u201383 (2017).","DOI":"10.1002\/bdd.2053"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wei ZF, Tong B, Xia YF, Lu Q, Chou GX, Wang ZT, Dai Y. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs\/NF-\u03baB\/c-Fos\/NFATc1 pathways. <i>PLOS ONE<\/i>, <b>8<\/b>, e59171 (2013).","DOI":"10.1371\/journal.pone.0059171"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Gouda MM, Bhandary YP. Acute lung injury. IL-17A-mediated inflammatory pathway and its regulation by curcumin. <i>Inflammation<\/i>, <b>42<\/b>, 1160\u20131169 (2019).","DOI":"10.1007\/s10753-019-01010-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Chen H, Bai C, Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. <i>Expert Rev. Respir. Med.<\/i>, <b>4<\/b>, 773\u2013783 (2010).","DOI":"10.1586\/ers.10.71"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Allard B, Panariti A, Martin JG. Alveolar macrophages in the resolution of inflammation, tissue repair, and tolerance to infection. <i>Front. Immunol.<\/i>, <b>9<\/b>, 1777 (2018).","DOI":"10.3389\/fimmu.2018.01777"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Frank JA, Wray CM, McAuley DF, Schwendener R, Matthay MA. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, <b>291<\/b>, L1191\u2013L1198 (2006).","DOI":"10.1152\/ajplung.00055.2006"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Huang X, Xiu H, Zhang S, Zhang G. The role of macrophages in the pathogenesis of ALI\/ARDS. <i>Mediators Inflamm.<\/i>, <b>2018<\/b>, 1264913 (2018).","DOI":"10.1155\/2018\/1264913"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Song C, Li H, Li Y, Dai M, Zhang L, Liu S, Tan H, Deng P, Liu J, Mao Z, Li Q, Su X, Long Y, Lin F, Zeng Y, Fan Y, Luo B, Hu C, Pan P. NETs promote ALI\/ARDS inflammation by regulating alveolar macrophage polarization. <i>Exp. Cell Res.<\/i>, <b>382<\/b>, 111486 (2019).","DOI":"10.1016\/j.yexcr.2019.06.031"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Zhang Y, Li X, Grailer JJ, Wang N, Wang M, Yao J, Zhong R, Gao GF, Ward PA, Tan DX, Li X. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. <i>J. Pineal Res.<\/i>, <b>60<\/b>, 405\u2013414 (2016).","DOI":"10.1111\/jpi.12322"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yang H, Lv H, Li H, Ci X, Peng L. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-\u03baB pathways. Cell Commun. Signal., <b>17<\/b>, 62 (2019).","DOI":"10.1186\/s12964-019-0366-y"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Ren Y, Qiao W, Fu D, Han Z, Liu W, Ye W, Liu Z. Traditional Chinese medicine protects against cytokine production as the potential immunosuppressive agents in atherosclerosis. <i>J. Immunol. Res.<\/i>, <b>2017<\/b>, 7424307 (2017).","DOI":"10.1155\/2017\/7424307"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Zhang JL, Li WX, Li Y, Wong MS, Wang YJ, Zhang Y. Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism. <i>Phytomedicine<\/i>, <b>85<\/b>, 153297 (2021).","DOI":"10.1016\/j.phymed.2020.153297"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wang WC, Xia YM, Yang B, Su XN, Chen JK, Li W, Jiang T. Protective effects of tyrosol against LPS-induced acute lung injury <i>via<\/i> inhibiting NF-\u03baB and AP-1 activation and activating the HO-1\/Nrf2 pathways. <i>Biol. Pharm. Bull.<\/i>, <b>40<\/b>, 583\u2013593 (2017).","DOI":"10.1248\/bpb.b16-00756"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kim ID, Ha BJ. Paeoniflorin protects RAW264.7 macrophages from LPS-induced cytotoxicity and genotoxicity. <i>Toxicol. In Vitro<\/i>, <b>23<\/b>, 1014\u20131019 (2009).","DOI":"10.1016\/j.tiv.2009.06.019"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Peng S, Gao J, Liu W, Jiang C, Yang X, Sun Y, Guo W, Xu Q. Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-\u03baB signaling and NLRP3 inflammasome activation. <i>Oncotarget<\/i>, <b>7<\/b>, 80262\u201380274 (2016).","DOI":"10.18632\/oncotarget.12918"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Luo Y, Liu M, Dai Y, Yao X, Xia Y, Chou G, Wang Z. Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW264.7 cells by down-regulating the activation of MAPKs but not NF-\u03baB. <i>Inflammation<\/i>, <b>33<\/b>, 389\u2013397 (2010).","DOI":"10.1007\/s10753-010-9197-0"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Kong Q, Li N, Cheng H, Zhang X, Cao X, Qi T, Dai L, Zhang Z, Chen X, Li C, Li Y, Xue B, Fang L, Liu L, Ding Z. HSPA12A Is a novel player in nonalcoholic steatohepatitis <i>via<\/i> promoting nuclear PKM2-mediated M1 macrophage polarization. <i>Diabetes<\/i>, <b>68<\/b>, 361\u2013376 (2019).","DOI":"10.2337\/db18-0035"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MA, Sheedy FJ, Gleeson LE, van den Bosch MW, Quinn SR, Domingo-Fernandez R, Johnston DG, Jiang JK, Israelsen WJ, Keane J, Thomas C, Clish C, Vander Heiden M, Xavier RJ, O\u2019Neill LA. Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages. <i>Cell Metab.<\/i>, <b>21<\/b>, 65\u201380 (2015).","DOI":"10.1016\/j.cmet.2014.12.005"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Yang L, Xie M, Yang M, Yu Y, Zhu S, Hou W, Kang R, Lotze MT, Billiar TR, Wang H, Cao L, Tang D. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. <i>Nat. Commun.<\/i>, <b>5<\/b>, 4436 (2014).","DOI":"10.1038\/ncomms5436"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Xu J, Jiang C, Wang X, Geng M, Peng Y, Guo Y, Wang S, Li X, Tao P, Zhang F, Han Y, Ning Q, Zhu W, Meng L, Lu S. Upregulated PKM2 in macrophages exacerbates experimental arthritis <i>via<\/i> STAT1 signaling. <i>J. Immunol.<\/i>, <b>205<\/b>, 181\u2013192 (2020).","DOI":"10.4049\/jimmunol.1901021"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Xu F, Guo M, Huang W, Feng L, Zhu J, Luo K, Gao J, Zheng B, Kong LD, Pang T, Wu X, Xu Q. Annexin A5 regulates hepatic macrophage polarization <i>via<\/i> directly targeting PKM2 and ameliorates NASH. <i>Redox Biol.<\/i>, <b>36<\/b>, 101634 (2020).","DOI":"10.1016\/j.redox.2020.101634"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Miller KN, Clark JP, Martin SA, Howell PR, Burhans MS, Haws SA, Johnson NB, Rhoads TW, Pavelec DM, Eliceiri KW, Roopra AS, Ntambi JM, Denu JM, Parks BW, Anderson RM. PGC-1a integrates a metabolism and growth network linked to caloric restriction. <i>Aging Cell<\/i>, <b>18<\/b>, e12999 (2019).","DOI":"10.1111\/acel.12999"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Bocco BM, Louzada RA, Silvestre DH, Santos MC, Anne-Palmer E, Rangel IF, Abdalla S, Ferreira AC, Ribeiro MO, Gereben B, Carvalho DP, Bianco AC, Werneck-de-Castro JP. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 expression in skeletal muscle. <i>J. Physiol.<\/i>, <b>594<\/b>, 5255\u20135269 (2016).","DOI":"10.1113\/JP272440"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Kim SY, Lee MS, Chang E, Jung S, Ko H, Lee E, Lee S, Kim CT, Kim IH, Kim Y. Tartary buckwheat extract attenuated the obesity-induced inflammation and increased muscle PGC-1a\/SIRT1 expression in high fat diet-induced obese rats. <i>Nutrients<\/i>, <b>11<\/b>, 654 (2019).","DOI":"10.3390\/nu11030654"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Schilling J, Lai L, Sambandam N, Dey CE, Leone TC, Kelly DP. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor \u03b3 coactivator-1 signaling. <i>Circ. Heart Fail.<\/i>, <b>4<\/b>, 474\u2013482 (2011).","DOI":"10.1161\/CIRCHEARTFAILURE.110.959833"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00457\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T07:04:51Z","timestamp":1633158291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/10\/44_b21-00457\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00457","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"b21-00457"}}